Cargando…
Correction: Thalidomide with blockade of costimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts
Autores principales: | Zhu, Maoshu, Ma, Yunhan, Tan, Kai, Zhang, Liyi, Wang, Zhaowei, Li, Yongsheng, Chen, Yingyu, Guo, Junjun, Yan, Guoliang, Qi, Zhongquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361527/ https://www.ncbi.nlm.nih.gov/pubmed/35945504 http://dx.doi.org/10.1186/s12865-022-00512-5 |
Ejemplares similares
-
Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts
por: Zhu, Maoshu, et al.
Publicado: (2020) -
Berberine Prolongs Mouse Heart Allograft Survival by Activating T Cell Apoptosis via the Mitochondrial Pathway
por: Ma, Yunhan, et al.
Publicado: (2021) -
Cd4(+)Cd25(+) Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade
por: Taylor, Patricia A., et al.
Publicado: (2001) -
Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade
por: Tomita, Yusuke, et al.
Publicado: (2016) -
Synergic silencing of costimulatory molecules prevents cardiac allograft rejection
por: Zhang, Xusheng, et al.
Publicado: (2014)